Nossegem, Belgium

Gwen Falony

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Katholieke Universiteit Leuven, Vib Vzw, Vrije Universiteit Brussel. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwen Falony. Retrieved from https://idiyas.com/inventor/gwen-falony

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gwen Falony: Innovator in Gut Inflammation Research

Introduction

Gwen Falony is a notable inventor based in Nossegem, Belgium. She has made significant contributions to the field of inflammation-associated disorders, particularly focusing on gut inflammation. Her innovative work has led to the development of methods for diagnosing and treating these conditions.

Latest Patents

Gwen Falony holds 1 patent titled "Inflammation associated, low cell count enterotype." This invention relates to the diagnosis and treatment of inflammation-associated disorders or conditions. It provides means and methods to reduce the severity of gut inflammation in subjects in need.

Career Highlights

Throughout her career, Gwen has worked with various organizations, including Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Gwen has collaborated with notable colleagues such as Jeroen Raes and Mireia Valles-Colomer. These partnerships have enriched her research and expanded the impact of her work in the field of gut health.

Conclusion

Gwen Falony's innovative contributions to gut inflammation research highlight her role as a leading inventor in this important area of health. Her work continues to influence the diagnosis and treatment of inflammation-associated disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…